Atjaunināt sīkdatņu piekrišanu

Flow Cytometry in Neoplastic Hematology: Morphologic-Immunophenotypic Correlation, Third Edition 3rd edition [Hardback]

3.33/5 (3 ratings by Goodreads)
(Hematopathologist, Bioreference Laboratories, Elmwood Park, NJ, USA; Regional Cancer Care Associates, Hackensack, NJ, USA)
  • Formāts: Hardback, 456 pages, height x width: 280x210 mm, weight: 1538 g, 35 Tables, black and white; 11 Line drawings, color; 479 Illustrations, color; 16 Illustrations, black and white
  • Izdošanas datums: 14-Aug-2017
  • Izdevniecība: Productivity Press
  • ISBN-10: 1498775020
  • ISBN-13: 9781498775021
Citas grāmatas par šo tēmu:
Flow Cytometry in Neoplastic Hematology: Morphologic-Immunophenotypic Correlation, Third Edition 3rd editionPalielināt
  • Formāts: Hardback, 456 pages, height x width: 280x210 mm, weight: 1538 g, 35 Tables, black and white; 11 Line drawings, color; 479 Illustrations, color; 16 Illustrations, black and white
  • Izdošanas datums: 14-Aug-2017
  • Izdevniecība: Productivity Press
  • ISBN-10: 1498775020
  • ISBN-13: 9781498775021
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781498775021.html
Keywords:

This third edition is the product of the author’s 25 years of experience with flow cytometry; although it covers the wide spectrum of hematopoietic tumors, the focus remains on most important clinical diagnoses, such as acute promyelocytic leukemia, identification of blasts, identification of clonal B-cell population, differentiating mature versus immature T-cell proliferations, deferential diagnosis between hematogones and B-ALL or distinction between chronic and acute monocytic proliferations. All hematopathologists and neoplastic hematologists will find this an important resource for keeping up to date with developments in clinical practice.

Recenzijas

The third edition of this book is a valuable addition. Not surprisingly, given that it comprises 456 pages, it is comprehensive. It is clearly written, well illustrated and supported by extensive references. The principles are thoroughly explained and there are 13 chapters dealing with individual diseases or groups of diseases. Flow cytometric immunophenotyping results are correlated with morphological characteristics and molecular/cytogenetic abnormalities. Limitations of the procedure are discussed. The text is up-to-date, incorporating the 2016 revision of the WHO classification of tumours of haemopoietic and lymphoid tumours. Since there is a great deal of detailed information, it will serve as a useful reference for immunophenotyping laboratories as well as being an educational tool for others. Barbara J. Bain, St Marys Hospital Campus of Imperial College London, Department of Haematology, British Journal of Haematology

Preface to the Third Edition vi
Abbreviations vii
1 Introduction
1(14)
2 Gating Strategies
15(10)
3 Classification of Hematopoietic Tumors
25(4)
4 Identification of Clonal B-Cell Populations
29(15)
5 Identification of Abnormal T-Cell Populations
44(16)
6 Identification of Myeloblasts
60(24)
7 Identification of B-Lymphoblasts
84(10)
8 Identification of T-Lymphoblasts
94(5)
9 Antigen Expression during Myeloid and Lymphoid Maturation
99(6)
10 Identification of Myelodysplastic Syndrome by Flow Cytometry
105(10)
11 Phenotypic Markers
115(11)
12 Morphologic-Flow Cytometric Correlation
126(19)
13 Molecular-Flow Cytometric Correlation
145(5)
14 Flow Cytometry Limitations
150(6)
15 Phenotypic Classification of B-Cell Lymphoproliferations
156(7)
16 Mature B-Cell Lymphoproliferations
163(64)
17 Plasma Cell Neoplasms
227(13)
18 Mature T/NK-Cell Lymphoproliferations
240(62)
19 Hodgkin Lymphoma
302(7)
20 B-Cell Lymphoblastic Leukemia/Lymphoma
309(13)
21 T-Cell Lymphoblastic Leukemia/Lymphoma
322(9)
22 Myelodysplastic Syndromes
331(10)
23 Chronic Myelomonocytic Leukemia and Other Myelodysplastic/Myeloproliferative Neoplasms
341(12)
24 Myeloproliferative Neoplasms
353(25)
25 Acute Myeloid Leukemia: Introduction
378(14)
26 Acute Myeloid Leukemia with Recurrent Genetic Changes
392(20)
27 Acute Myeloid Leukemia, Not Otherwise Specified
412(22)
28 Other Tumors
434(17)
Index 451
Wojciech Gorczyca MD, PhD, currently works at Bioreference Laboratories as Medical Director of Flow Cytometry and Chief for Hematopathology Services. A noted authority in clinical flow cytometry and hematopathology, he served for more than ten years as a hematopathologist and director of hematopathology with Genzyme Genetics, Inc. / IMPATH, Inc. and later with CSI Laboratories medical team where he worked as director of flow cytometry.